|
1.
|
Barratt J and Feehally J: IgA nephropathy.
J Am Soc Nephrol. 16:2088–2097. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Barratt J, Smith AC, Molyneux K and
Feehally J: Immunopathogenesis of IgAN. Semin Immunopathol.
29:427–443. 2007. View Article : Google Scholar
|
|
3.
|
Chen D, Zhao M and Mundy GR: Bone
morphogenetic proteins. Growth Factors. 22:233–241. 2004.
View Article : Google Scholar
|
|
4.
|
Maciel TT, Kempf H and Campos AH:
Targeting bone morphogenetic protein signaling on renal and
vascular diseases. Curr Opin Nephrol Hypertens. 19:26–31. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Simic P and Vukicevic S: Bone
morphogenetic proteins in development and homeostasis of kidney.
Cytokine Growth Factor Rev. 16:299–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yang YL, Liu YS, Chuang LY, et al: Bone
morphogenetic protein-2 antagonizes renal interstitial fibrosis by
promoting catabolism of type I transforming growth factor-beta
receptors. Endocrinology. 150:727–740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Iwasaki S, Tsuruoka N, Hattori A, Sato M,
Tsujimoto M and Kohno M: Distribution and characterization of
specific cellular binding proteins for bone morphogenetic
protein-2. J Biol Chem. 270:5476–5482. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ghosh Choudhury G, Kim YS, Simon M, et al:
Bone morphogenetic protein 2 inhibits platelet-derived growth
factor-induced c-fos gene transcription and DNA synthesis in
mesangial cells. Involvement of mitogen-activated protein kinase. J
Biol Chem. 274:10897–10902. 1999.
|
|
9.
|
Ghosh Choudhury G, Jin DC, Kim Y, Celeste
A, Ghosh-Choudhury N and Abboud HE: Bone morphogenetic protein-2
inhibits MAPK-dependent Elk-1 transactivation and DNA synthesis
induced by EGF in mesangial cells. Biochem Biophys Res Commun.
258:490–496. 1999.PubMed/NCBI
|
|
10.
|
Pache G, Schafer C, Wiesemann S, et al:
Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen
species in podocytes. Am J Physiol Renal Physiol. 291:F654–F662.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Chan WL, Leung JC, Chan LY, Tam KY, Tang
SC and Lai KN: BMP-7 protects mesangial cells from injury by
polymeric IgA. Kidney Int. 74:1026–1039. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Sole X, Guino E, Valls J, Iniesta R and
Moreno V: SNPStats: a web tool for the analysis of association
studies. Bioinformatics. 22:1928–1929. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Gabriel SB, Schaffner SF, Nguyen H, et al:
The structure of haplotype blocks in the human genome. Science.
296:2225–2229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Nguyen TQ, Roestenberg P, van Nieuwenhoven
FA, et al: CTGF inhibits BMP-7 signaling in diabetic nephropathy. J
Am Soc Nephrol. 19:2098–2107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Park Y, Kim JW, Kim DS, et al: The bone
morphogenesis protein-2 (BMP-2) is associated with progression to
metastatic disease in gastric cancer. Cancer Res Treat. 40:127–132.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ara J, See J, Mamontov P, et al: Bone
morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal
cord during experimental autoimmune encephalomyelitis. J Neurosci
Res. 86:125–135. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Weiskirchen R, Meurer SK, Gressner OA,
Herrmann J, Borkham-Kamphorst E and Gressner AM: BMP-7 as
antagonist of organ fibrosis. Front Biosci. 14:4992–5012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Rosen V: BMP2 signaling in bone
development and repair. Cytokine Growth Factor Rev. 20:475–480.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Langenfeld EM, Calvano SE, Abou-Nukta F,
Lowry SF, Amenta P and Langenfeld J: The mature bone morphogenetic
protein-2 is aberrantly expressed in non-small cell lung carcinomas
and stimulates tumor growth of A549 cells. Carcinogenesis.
24:1445–1454. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kleeff J, Maruyama H, Ishiwata T, et al:
Bone morphogenetic protein 2 exerts diverse effects on cell growth
in vitro and is expressed in human pancreatic cancer in vivo.
Gastroenterology. 116:1202–1216. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Liu C, Tian G, Tu Y, Fu J, Lan C and Wu N:
Expression pattern and clinical prognostic relevance of bone
morphogenetic protein-2 in human gliomas. Jpn J Clin Oncol.
39:625–631. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Baelde HJ, Eikmans M, Doran PP, Lappin DW,
de Heer E and Bruijn JA: Gene expression profiling in glomeruli
from human kidneys with diabetic nephropathy. Am J Kidney Dis.
43:636–650. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Dalfino G, Simone S, Porreca S, et al:
Bone morphogenetic protein-2 may represent the molecular link
between oxidative stress and vascular stiffness in chronic kidney
disease. Atherosclerosis. 211:418–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Sieber C, Kopf J, Hiepen C and Knaus P:
Recent advances in BMP receptor signaling. Cytokine Growth Factor
Rev. 20:343–355. 2009. View Article : Google Scholar : PubMed/NCBI
|
